Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

Mads Holten-Andersen; Ross Stephens; Hans Jørgen Nielsen; Ib Jarle Christensen; Nils Brünner

Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

Mads Holten-Andersen (Inventor), Ross Stephens (Inventor), Hans Jørgen Nielsen (Inventor), Ib Jarle Christensen (Inventor), Nils Brünner (Inventor)

Department of Clinical Medicine

Abstract

The present invention describes a method for determining whether an individual is likely to have cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.

Original language	English
Patent number	US 2007/0020707 A1
Filing date	09/06/2006
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://www.google.com/patents?id=4MWXAAAAEBAJ&dq=hvidovre+hospital

Cite this

@misc{88be8015ba434c22b211a6881aee1523,

title = "Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker",

abstract = "The present invention describes a method for determining whether an individual is likely to have cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.",

author = "Mads Holten-Andersen and Ross Stephens and Nielsen, {Hans J{\o}rgen} and Christensen, {Ib Jarle} and Nils Br{\"u}nner",

note = "U.S. Classification 435007230; US 2007/0020707 A1",

year = "2006",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

AU - Holten-Andersen, Mads

AU - Stephens, Ross

AU - Nielsen, Hans Jørgen

AU - Christensen, Ib Jarle

AU - Brünner, Nils

N1 - U.S. Classification 435007230

PY - 2006

Y1 - 2006

N2 - The present invention describes a method for determining whether an individual is likely to have cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.

AB - The present invention describes a method for determining whether an individual is likely to have cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.

M3 - Patent

M1 - US 2007/0020707 A1

Y2 - 2006/06/09

ER -

Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this